STAAR SURGICAL COMPANY AQUAFLOW(TM) COLLAGEN GLAUCOMA DRAINAGE DEVICE, MODEL CGDD-20

FDA Premarket Approval P000026

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the model cgdd-20 aquaflow(tm) collagen drainage device. The device is indicated for the maintenance of a sub-scleral space following non-penetrating deep sclerectomy used to facilitate aqueous outflow for the reduction of intraocular pressure in patients with open angle glaucoma where intraocular pressure remains uncontrolled while on maximally tolerated medical therapy.

DeviceSTAAR SURGICAL COMPANY AQUAFLOW(TM) COLLAGEN GLAUCOMA DRAINAGE DEVICE, MODEL CGDD-20
Generic NameIntraocular Pressure Lowering Implant
ApplicantSTARR SURGICAL CO.
Date Received2000-07-07
Decision Date2001-07-12
Notice Date2001-07-23
PMAP000026
SupplementS
Product CodeOGO 
Docket Number01M-0307
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address STARR SURGICAL CO. 1911 Walker Ave. monrovia, CA 91016
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P000026Original Filing
S003 2010-05-01 Real-time Process
S002 2009-02-09 30-day Notice
S001 2008-07-23 135 Review Track For 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.